Key facts
- New York Ventures is a venture capital firm based in New York, New York with 59 tracked portfolio companies.
- Notable positions include ZetaGen Therapeutics, Envisagenics, Owl AI.
- New York Ventures has 21 funds on record, raising $2.0B across the 20 that report a size.
About New York Ventures
Founded in 2015, New York Ventures is the venture capital arm of Empire State Development, based in New York, New York. The firm prefers to invest in early-stage companies in advanced manufacturing, agricultural tech, climate and energy tech, consumer tech, data, software as a service, artificial intelligence, deep tech, fintech, healthcare, life sciences and biotech, and medical devices sectors.
Free account
See more of the book
- ·The top 10 names in the book — of 59 recorded positions
- ·Watchlist + alerts for New York Ventures's activity
Create free account
No card required
Portfolio
59 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| ZetaGen Therapeutics | — | ▮ | ▮ | ▮ |
| Envisagenics | — | ▮ | ▮ | ▮ |
| Owl AI | — | ▮ | ▮ | ▮ |
+ 56 more companies · all 59, priced and dated or a free account shows the top 10 names — no card | ||||
Funds
6 of 21 recorded- New York Social Equity Cannabis Investment Fund, L.P.2023$15.0M
- New York - 80 South Coinvest, LP2022$107.4M
- New York Credit SBIC Fund II L.P.2022$73.0M
- New York Balanced Pool Asia Investors IV, LP2021$212.7M
- New York Co-Investment Pool Asia Investors IV, LP2021$190.5M
- New York City Property Fund II LP2020$3.5M
$2.0B raised across the 20 funds that report a size
All 21 funds →Frequently asked
- What companies does New York Ventures invest in?
- New York Ventures has 59 recorded portfolio companies, including ZetaGen Therapeutics, Envisagenics, Owl AI.
- What is New York Ventures's AUM?
- New York Ventures manages approximately $317.0M in assets.